Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Lewis
NCRI UK
Principal Investigator - Steven Le Gouill
Lymphoma Study Association
Principal Investigator - Toby Eyre
NCRI UK
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
45 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- A.Z. Sint Jan Av
Bruges, Belgium
- Universite Libre de Bruxelles - Hopital Erasme
Brussels, Belgium
- Hopital Jolimont
Haine-Saint-Paul, Belgium
- Chu de Liege
Liège, Belgium
- Universite Catholique de Louvain Mont Godinne
Yvoir, Belgium
- Chu D'Angers
Angers, France
- Ch D'Avignon - Hopital Henri Duffaut
Avignon, France
- Ch de la Côte Basque
Bayonne, France
- Chu Jean Minioz
Besançon, France
- Chu de Brest - Hopital de la Cavale Blanche
Brest, France
- Institut D'Hématologie de Basse Normandie
Caen, France
- Chu Estaing
Clermont-Ferrand, France
- Ch Henri Mondor
Créteil, France
- Chu de Dijon
Dijon, France
- Chd de Vendée
La Roche-sur-Yon, France
- Chu de Grenoble
La Tronche, France
- Chru de Lille
Lille, France
- Hopital Dupuytren
Limoges, France
- Centre Léon Bérard
Lyon, France
- Institut Paoli Calmettes
Marseille, France
- Chu de Montpellier
Montpellier, France
- Chu de Nantes
Nantes, France
- Hopital Necker
Paris, France
- Hopital St-Louis
Paris, France
- Chu de Bordeaux - Hopital Haut-Leveque - Centre Francois Magendie
Pessac, France
- Centre Hospitalier Lyon Sud
Pierre-Bénite, France
- Hopital de la Milétrie
Poitiers, France
- Ch Annecy Gennevois
Pringy, France
- Ch de Cornouaille
Quimper, France
- Chu de Reims
Reims, France
- Chu Pontchaillou
Rennes, France
- Centre Henri Becquerel
Rouen, France
- Hopital René Huguenin
Saint-Cloud, France
- Institut de Cancérologie de la Loire Lucien Neuwirth
Saint-Priest-en-Jarez, France
- Institut de Cancérologie Strasbourg Europe
Strasbourg, France
- Iuct Oncopole
Toulouse, France
- Chu Bretonneau
Tours, France
- Chu Nancy Brabois
Vandœuvre-lès-Nancy, France
- Ch de Bretagne Atlantique - Hopital Chubert
Vannes, France
- Institut Gustave Roussy
Villejuif, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Jan 2022
- Primary completion
- 31 Mar 2028
- Completion
- 30 Sept 2031
- Last update posted
- 20 May 2026
- Registered enrollment
- 210
- Registry id
- NCT04802590
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.